Plain-English translation of NCT05548283 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Cystic Fibrosis research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether adding antibiotics to standard beta-lactam antibiotics works better than beta-lactam antibiotics alone when treating a lung infection flare-up in cystic fibrosis. You would receive one of these two antibiotic combinations by IV for 14 days, and researchers would measure how well your lungs are working before and after treatment to compare the results.
Doctors don't yet have clear evidence about the best way to treat lung infection flare-ups in cystic fibrosis. This trial will help establish which antibiotic approach gives patients the best outcomes.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the standard antibiotic treatment or the standard treatment plus the additional medication. You'll visit the clinic at the start of treatment and again 28 days later for lung function testing and other measurements to see how well the treatment worked. Throughout the study, your doctor will monitor you for any side effects or complications.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States